European Patent Office rules in favor of Sanofi and Regeneron concerning Praluent (alirocumab) Ruling invalidates Amgen's European patent claims directed to PCSK9 antibodies relevant to Pral..查看文章
(RTTNews) - The European Patent Office ruled in in favor of Sanofi (SNYNF, SNY) and Regeneron concerning Praluent or alirocumab. The ruling also invalidates Amgen's European patent claims di..查看文章
Praluent will continue to be available in European countries where it is approved for use and for sale. “We are pleased with this decision by the European Patent Office, which upholds the ri..查看文章
Technical Boards of Appeal has today ruled in Sanofi and Regeneron's favor, invalidating certain claims of Amgen's European patent (EP 2 215 124) directed to PCSK9 (proprotein convertase sub..查看文章
Technical Boards of Appeal has ruled in Sanofi and Regeneron's favor, invalidating certain claims of Amgen's European patent (EP 2 215 124) directed to PCSK9 (proprotein convertase subtilisi..查看文章
Praluent与发音含义,同义词,反义词,翻译,刑和更多的